Citation: M. Terai et Rd. Burk, Characterization of a novel genital human papillomavirus by overlapping PCR: candHPV86 identified in cervicovaginal cells of a woman with cervical neoplasia, J GEN VIROL, 82, 2001, pp. 2035-2040
Authors:
Okamoto, H
Nishizawa, T
Takahashi, M
Tawara, A
Peng, YH
Kishimoto, J
Wang, Y
Citation: H. Okamoto et al., Genomic and evolutionary characterization of TT virus (TTV) in tupaias andcomparison with species-specific TTVs in humans and non-human primates, J GEN VIROL, 82, 2001, pp. 2041-2050
Authors:
Sollerbrant, K
Elmen, J
Wahlestedt, C
Acker, J
Leblois-Prehaud, H
Latta-Mahieu, M
Yeh, P
Perricaudet, M
Citation: K. Sollerbrant et al., A novel method using baculovirus-mediated gene transfer for production of recombinant adeno-associated virus vectors, J GEN VIROL, 82, 2001, pp. 2051-2060
Authors:
Benz, C
Reusch, U
Muranyi, W
Brune, W
Atalay, R
Hengel, H
Citation: C. Benz et al., Efficient downregulation of major histocompatibility complex class I molecules in human epithelial cells infected with cytomegalovirus, J GEN VIROL, 82, 2001, pp. 2061-2070
Authors:
Koppers-Lalic, D
Rijsewijk, FAM
Verschuren, SBE
van Gaans-van den Brink, JAM
Neisig, A
Ressing, ME
Neefjes, J
Wiertz, EJHJ
Citation: D. Koppers-lalic et al., The UL41-encoded virion host shutoff (vhs) protein and vhs-independent mechanisms are responsible for down-regulation of MHC class I molecules by bovine herpesvirus 1, J GEN VIROL, 82, 2001, pp. 2071-2081
Authors:
Gardner, JD
Tscharke, DC
Reading, PC
Smith, GL
Citation: Jd. Gardner et al., Vaccinia virus semaphorin A39R is a 50-55 kDa secreted glycoprotein that affects the outcome of infection in a murine intradermal model, J GEN VIROL, 82, 2001, pp. 2083-2093
Citation: A. Ng et al., The vaccinia virus A41L protein is a soluble 30 kDa glycoprotein that affects virus virulence, J GEN VIROL, 82, 2001, pp. 2095-2105
Citation: Tr. Johnson et al., Construction and characterization of recombinant vaccinia viruses co-expressing a respiratory syncytial virus protein and a cytokine, J GEN VIROL, 82, 2001, pp. 2107-2116
Authors:
Venter, M
Madhi, SA
Tiemessen, CT
Schoub, BD
Citation: M. Venter et al., Genetic diversity and molecular epidemiology of respiratory syncytial virus over four consecutive seasons in South Africa: identification of new subgroup A and B genotypes, J GEN VIROL, 82, 2001, pp. 2117-2124
Authors:
Evlashev, A
Valentin, H
Rivailler, P
Azocar, O
Rabourdin-Combe, C
Horvat, B
Citation: A. Evlashev et al., Differential permissivity to measles virus infection of human and CD46-transgenic murine lymphocytes, J GEN VIROL, 82, 2001, pp. 2125-2129
Authors:
Herberts, CA
Stittelaar, KJ
van der Heeft, E
van Ganns-van den Brink, J
Poelen, MCM
Roholl, PJM
van Alphen, LJW
Melief, CJM
de Jong, APJM
van Els, CACM
Citation: Ca. Herberts et al., A measles virus glycoprotein-derived human CTL epitope is abundantly presented via the proteasomal-dependent MHC class I processing pathway, J GEN VIROL, 82, 2001, pp. 2131-2142
Authors:
Nakayama, T
Komase, K
Uzuka, R
Hoshi, A
Okafuji, T
Citation: T. Nakayama et al., Leucine at position 278 of the AIK-C measles virus vaccine strain fusion protein is responsible for reduced syncytium formation, J GEN VIROL, 82, 2001, pp. 2143-2150
Authors:
Nakagawa, N
Kubota, R
Nakagawa, T
Okuno, Y
Citation: N. Nakagawa et al., Antigenic variants with amino acid deletions clarify a neutralizing epitope specific for influenza B virus Victoria group strains, J GEN VIROL, 82, 2001, pp. 2169-2172
Authors:
Vos, A
Neubert, A
Pommerening, E
Muller, T
Dohner, L
Neubert, L
Hughes, K
Citation: A. Vos et al., Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration, J GEN VIROL, 82, 2001, pp. 2191-2197
Authors:
Dauphin, G
Legay, V
Sailleau, C
Smondack, S
Hammoumi, S
Zientara, S
Citation: G. Dauphin et al., Evidence of Borna disease virus genome detection in French domestic animals and in foxes (Vulpes vulpes), J GEN VIROL, 82, 2001, pp. 2199-2204
Citation: T. Burmeister et al., A PCR primer system for detecting oncoretroviruses based on conserved DNA sequence motifs of animal retroviruses and its application to human leukaemias and lymphomas, J GEN VIROL, 82, 2001, pp. 2205-2213
Authors:
Sharpe, S
Polyanskaya, N
Dennis, M
Sutter, G
Hanke, T
Erfle, V
Hirsch, V
Cranage, M
Citation: S. Sharpe et al., Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity, J GEN VIROL, 82, 2001, pp. 2215-2223
Authors:
Canto-Nogues, C
Jones, S
Sangster, R
Silvera, P
Hull, R
Cook, R
Hall, G
Walker, B
Stott, EJ
Hockley, D
Almond, N
Citation: C. Canto-nogues et al., In situ hybridization and immunolabelling study of the early replication of simian immunodeficiency virus (SIVmacJ5) in vivo, J GEN VIROL, 82, 2001, pp. 2225-2234
Authors:
Ciccaglione, AR
Costantino, A
Marcantonio, C
Equestre, M
Geraci, A
Rapicetta, M
Citation: Ar. Ciccaglione et al., Mutagenesis of hepatitis C virus E1 protein affects its membrane-permeabilizing activity, J GEN VIROL, 82, 2001, pp. 2243-2250